Hyperion Therapeutics (HPTX) to Resume Trading at 3:20pm ET
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Hyperion Therapeutics (HPTX) Resumes; Shares Move Lower
February 1, 2013 3:21 PM ESTHyperion Therapeutics (NASDAQ: HPTX) resumes trading, shares are dipping at the start.... More
Hyperion Therapeutics (HPTX) RAVICTI Receives FDA Approval
February 1, 2013 3:02 PM ESTHyperion Therapeutics, Inc. (Nasdaq: HPTX) announced that the U.S. Food and Drug Administration (FDA) has approved RAVICTI for the treatment of Urea Cycle Disorders (UCD) in patients two years of age and older. The drug is expected to be commercially available by the end of April 2013.
Separately, Hyperion announced it has received notification from the U.S. Patent & Trademark Office (USPTO) of... More
Hyperion Therapeutics (HPTX) halted, news pending
February 1, 2013 12:17 PM ESTHyperion Therapeutics (NASDAQ: HPTX) halted, news pending... More
